Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs



Rating:

Share or cite this content

Citations should be made in the following way:
S. Turner (Aberdeen (Aberdeenshire), United Kingdom), S. Cotton (Aberdeen (Aberdeenshire), United Kingdom), J. Wood (Aberdeen (Aberdeenshire), United Kingdom), V. Bell (Aberdeen (Aberdeenshire), United Kingdom), A. Raja (Aberdeen (Aberdeenshire), United Kingdom), N. Scott (Aberdeen (Aberdeenshire), United Kingdom), S. Fielding (Aberdeen (Aberdeenshire), United Kingdom), G. Maclennan (Aberdeen (Aberdeenshire), United Kingdom), E. Gaillard (Leicester, United Kingdom), M. Pijnenburg (Rotterdam, Netherlands), M. Thomas (Southampton, United Kingdom), D. Price (Aberdeen, United Kingdom). Reducing Asthma Attacks in Children using Exhaled Nitric Oxide as a biomarker to inform treatment strategy: a randomised trial (RAACENO). 2899

Member's Comments

No comment yet.

Related content which might interest you: Exhaled nitric oxide and the therapeutic regimens in childhood asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Exhaled NO levels – A new tool in decision-making about antibiotic treatment Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Does Exhaled Nitric Oxide Correlate with Established Measures of Asthma Severity? Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Can Exhaled Nitric Oxide Be a Biomarker for Hospitalized and Post-COVID-19 Patients? Source: Virtual Congress 2021 – Biological and functional markers of COVID-19 Year: 2021 Exhaled nitric oxide (FeNO) levels to guide treatment for children with asthma: A Cochrane systematic review Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016 Exhaled nitric oxide (FeNO) levels to guide treatment for adults with asthma: A Cochrane systematic review Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Further evidence that FeNO directed therapy reduces asthma exacerbations Source: International Congress 2014 – Airway biomarkers Year: 2014 Cost savings using fractional exhaled nitric oxide (FeNO) testing in asthma management by specialists Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Correlation between Blood Eosinophilia and Fractional Exhaled Nitric Oxide in the diagnosis of Asthma within Primary Care. Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Late Breaking Abstract - Management of asthma in pregnancy using fractional exhaled nitric oxide (FENO) to adjust inhaled corticosteroid (ICS) dose did not improve perinatal outcomes: the Breathing for Life Trial (BLT) Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020 Interaction between airway calibre and exhaled NO: Impact on asthma control assessment Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Normal values of exhaled nitric oxide at 50 mL/s – A revisit Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Exhaled nitric oxide in asthma: Relationship with breath gymnastic and FeNO levels Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers Year: 2015 Asthma exacerbations and exhaled nitric oxide: a randomised controlled trial Source: Eur Respir J 2006; 28: Suppl. 50, 572s Year: 2006 Validation of ATS cut-off points for FeNO in a clinical unselected population of subjects with possible asthma Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide Source: Guideline 2005 Year: 2005 The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Exhaled nitric oxide and the risk of wheezing in infancy: the Generation R Study Source: Eur Respir J 2012; 39: 567-572 Year: 2012 Exhaled NO (FENO50) in COPD - Results from the TIE-study Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Economic evaluation of fractional exhaled nitric oxide (FENO) for the management of adult asthma in Spain Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015